Two Cases of Severe Hypertension in JAK2 Mutation-Positive Myeloproliferative Neoplasms

Background. Myeloproliferative neoplasms are a heterogeneous group of disorders resulting from the abnormal proliferation of one or more terminal myeloid cells—established complications include thrombosis and haemorrhagic events; however, there is limited evidence to suggest an association with arte...

Full description

Saved in:
Bibliographic Details
Main Authors: Raunak Rao, Spoorthy Kulkarni, Ian B. Wilkinson
Format: Article
Language:English
Published: Wiley 2020-01-01
Series:Case Reports in Vascular Medicine
Online Access:http://dx.doi.org/10.1155/2020/8887423
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832566499530768384
author Raunak Rao
Spoorthy Kulkarni
Ian B. Wilkinson
author_facet Raunak Rao
Spoorthy Kulkarni
Ian B. Wilkinson
author_sort Raunak Rao
collection DOAJ
description Background. Myeloproliferative neoplasms are a heterogeneous group of disorders resulting from the abnormal proliferation of one or more terminal myeloid cells—established complications include thrombosis and haemorrhagic events; however, there is limited evidence to suggest an association with arterial hypertension. Herein, we report two independent cases of severe hypertension in JAK2 mutation-positive myeloproliferative neoplasms. Case Presentations. Case 1: a 39-year-old male was referred to our specialist hypertension unit with high blood pressure (BP) (200/120 mmHg), erythromelalgia, and headaches. We recorded elevated serum creatinine levels (146 μM) and panmyelosis. Bone marrow biopsy confirmed JAK2-mutation-positive polycythaemia vera. Renal imaging revealed renal artery stenosis. Aspirin, long-acting nifedipine, interferon-alpha 2A, and renal artery angioplasty were employed in management. BP reached below target levels to an average of 119/88 mmHg. Renal parameters normalised gradually alongside BP. Case 2: a 45-year-old male presented with high BP (208/131 mmHg), acrocyanosis, (vasculitic) skin rashes, and nonhealing ulcers. Fundoscopy showed optic disc blurring in the left eye and full blood count revealed thrombocytosis. Bone marrow biopsy confirmed JAK2-mutation-positive essential thrombocytosis. No renal artery stenosis was found. Cardiac output was measured at 5 L/min using an inert gas rebreathing method, providing an estimated peripheral vascular resistance of 1840 dynes/s/cm5. BP was well-controlled (reaching 130/70 mmHg) with CCBs. Conclusions. These presentations highlight the utility of full blood count analysis in patients with severe hypertension. Hyperviscosity and constitutive JAK-STAT activation are amongst the proposed pathophysiology linking myeloproliferative neoplasms and hypertension. Further experimental and clinical research is necessary to identify and understand possible interactions between BP and myeloproliferative neoplasms.
format Article
id doaj-art-b5622cdb9b1440edb94f9d1b6b83fe93
institution Kabale University
issn 2090-6986
2090-6994
language English
publishDate 2020-01-01
publisher Wiley
record_format Article
series Case Reports in Vascular Medicine
spelling doaj-art-b5622cdb9b1440edb94f9d1b6b83fe932025-02-03T01:03:58ZengWileyCase Reports in Vascular Medicine2090-69862090-69942020-01-01202010.1155/2020/88874238887423Two Cases of Severe Hypertension in JAK2 Mutation-Positive Myeloproliferative NeoplasmsRaunak Rao0Spoorthy Kulkarni1Ian B. Wilkinson2Division of Experimental Medicine and Immunotherapeutics, University of Cambridge, Cambridge, UKDivision of Experimental Medicine and Immunotherapeutics, University of Cambridge, Cambridge, UKDivision of Experimental Medicine and Immunotherapeutics, University of Cambridge, Cambridge, UKBackground. Myeloproliferative neoplasms are a heterogeneous group of disorders resulting from the abnormal proliferation of one or more terminal myeloid cells—established complications include thrombosis and haemorrhagic events; however, there is limited evidence to suggest an association with arterial hypertension. Herein, we report two independent cases of severe hypertension in JAK2 mutation-positive myeloproliferative neoplasms. Case Presentations. Case 1: a 39-year-old male was referred to our specialist hypertension unit with high blood pressure (BP) (200/120 mmHg), erythromelalgia, and headaches. We recorded elevated serum creatinine levels (146 μM) and panmyelosis. Bone marrow biopsy confirmed JAK2-mutation-positive polycythaemia vera. Renal imaging revealed renal artery stenosis. Aspirin, long-acting nifedipine, interferon-alpha 2A, and renal artery angioplasty were employed in management. BP reached below target levels to an average of 119/88 mmHg. Renal parameters normalised gradually alongside BP. Case 2: a 45-year-old male presented with high BP (208/131 mmHg), acrocyanosis, (vasculitic) skin rashes, and nonhealing ulcers. Fundoscopy showed optic disc blurring in the left eye and full blood count revealed thrombocytosis. Bone marrow biopsy confirmed JAK2-mutation-positive essential thrombocytosis. No renal artery stenosis was found. Cardiac output was measured at 5 L/min using an inert gas rebreathing method, providing an estimated peripheral vascular resistance of 1840 dynes/s/cm5. BP was well-controlled (reaching 130/70 mmHg) with CCBs. Conclusions. These presentations highlight the utility of full blood count analysis in patients with severe hypertension. Hyperviscosity and constitutive JAK-STAT activation are amongst the proposed pathophysiology linking myeloproliferative neoplasms and hypertension. Further experimental and clinical research is necessary to identify and understand possible interactions between BP and myeloproliferative neoplasms.http://dx.doi.org/10.1155/2020/8887423
spellingShingle Raunak Rao
Spoorthy Kulkarni
Ian B. Wilkinson
Two Cases of Severe Hypertension in JAK2 Mutation-Positive Myeloproliferative Neoplasms
Case Reports in Vascular Medicine
title Two Cases of Severe Hypertension in JAK2 Mutation-Positive Myeloproliferative Neoplasms
title_full Two Cases of Severe Hypertension in JAK2 Mutation-Positive Myeloproliferative Neoplasms
title_fullStr Two Cases of Severe Hypertension in JAK2 Mutation-Positive Myeloproliferative Neoplasms
title_full_unstemmed Two Cases of Severe Hypertension in JAK2 Mutation-Positive Myeloproliferative Neoplasms
title_short Two Cases of Severe Hypertension in JAK2 Mutation-Positive Myeloproliferative Neoplasms
title_sort two cases of severe hypertension in jak2 mutation positive myeloproliferative neoplasms
url http://dx.doi.org/10.1155/2020/8887423
work_keys_str_mv AT raunakrao twocasesofseverehypertensioninjak2mutationpositivemyeloproliferativeneoplasms
AT spoorthykulkarni twocasesofseverehypertensioninjak2mutationpositivemyeloproliferativeneoplasms
AT ianbwilkinson twocasesofseverehypertensioninjak2mutationpositivemyeloproliferativeneoplasms